Health economics workshop - PowerPoint PPT Presentation

1 / 39
About This Presentation
Title:

Health economics workshop

Description:

... we need to improve the design, conduct, analysis and reporting of ... 1. Health Reviews Ltd, UK. 2. Campbell and Cochrane Economics Methods Group. JAMA 2001 ... – PowerPoint PPT presentation

Number of Views:22
Avg rating:3.0/5.0
Slides: 40
Provided by: miranda81
Category:

less

Transcript and Presenter's Notes

Title: Health economics workshop


1
Health economics workshop
  • 11th annual meeting for UK contributors to the
    Cochrane Collaboration
  • Weston room 2
  • 16.15-17.45

2
  • Miranda Mugford
  • Co-convenor (chair)
  • Campbell-Cochrane Economics Methods Group
  • m.mugford_at_uea.ac.uk
  • v.knights_at_uea.ac.uk (admin coordination)
  • http//www.cochrane.org/contact/mwgfield.htm32
  • www.med.uea.ac.uk/research/research_econ/cochrane/
    cochrane_home.htm

3
Aims of the joint CCEMG group
  • Promote and support consideration of economics in
    the Collaborations
  • Develop economic methods for reviews
  • Undertake empirical research
  • Link reviewers with economics specialists
  • Review validity of economics methods
  • Disseminate valid methods and good practice
  • Relate to other methods groups

4
NHS Economic evaluation database
  • Pre-dated CCEMG
  • Autonomous entity based in CRD York
  • Included in Cochrane Library since 2000
  • Research agenda
  • links with Cochrane Reviews,
  • uses of NHS EED abstracts..
  • other topics ..

5
In the next 90 minutes...
  • Introduction and aim 10 mins
  • Revision of economics concepts 15 mins
  • Incorporating economics in reviews 10 mins
  • Discussion of examples 45 mins
  • Summing up 10 mins

6
Aim of the session
  • To help reviewers to decide
  • whether and how to incorporate
  • the economic dimension
  • in their reviews.

7
Who is here ?
  • Names and Cochrane entities of those present

8
Introduction to economic concepts and economic
evaluation
9
(No Transcript)
10
What needs to be known before adopting a
technology or new practice?
  • Does it work?
  • Is it worthwhile?

11
Decision model health decision
12
Costs and decisions
13
Decision model economic decision
14
Economic decision model
  • Effectiveness Outcome 1 Outcome 2
  • Incremental cost Cost 1- Cost 2
  • Cost effectiveness (incremental cost) /
    (incremental effectiveness)

15
Outcome measures matter for economic decisions
  • Length and quality of life may be affected in
    opposite directions
  • Economic decisions may require comparisons of
    interventions in different health sectors
  • Health outcomes may not be the only benefits of
    health care people value other things too

16
two key economic concepts
  • marginal analysis
  • opportunity cost

17
opportunity cost
  • Resources are scarce
  • Choices must be made
  • Every time choose to use resources to meet one
    need, we give up the "opportunity" to use those
    resources to meet some other need.
  • The benefits associated with the best alternative
    use of the resources is the OPPORTUNITY COST
  • The aim of economics is to ensure that we do
    those activities whose benefits outweigh their
    opportunity cost
  • In other words, we try to do the most beneficial
    things with the resources at our disposal

18
Screening for cancer of the colon if it works,
is more always better?
  • marginal analysis

19
Screening for cancer of the colon
  • Cases detected and costs of screening with six
    sequential tests,10,000 screened
  • No. of tests Cases found Total costs ()
    Av. cost ()
  • 1 65.9469 77,511 1175
  • 2 71.4424 107,690 1507
  • 3 71.9003 130,199 1811
  • 4 71.9385 148,116 2059
  • 5 71.9417 163,141 2268
  • 6 71.9420 176,331 2451

20
Screening for cancer of the colon
  • Incremental cases detected and incremental (and
    marginal) costs of screening with six sequential
    tests
  • No. of tests Incremental Incremental
    Marginal
  • cases detected costs ()
    costs ()
  • 1 65.9469 77,511 1175
  • 2 5.4956 30,179 5494
  • 3 0.4580 22,509
    49,150
  • 4 0.0382 17,917
    469,534
  • 5 0.0032 15,024
    4,724,695
  • 6 0.0003 13,190
    47,107,214

21
Implications of opportunity cost and marginal
analysis
  • to do more of some things, we have to take
    resources from elsewhere
  • by doing the same things at less cost
  • by taking resources from an effective area of
    care because a new intervention is more effective
    per spent
  • need to measure costs and benefits of health care
  • often about how much rather than whether

22
Framework for decision making
  • Any decision to change the way care is delivered
    will affect OUTCOME. This will
  • increase A
  • remain unchanged B
  • decrease C
  • not enough information D

23
Framework for decision making
  • Any decision to change the way care is delivered
    will impact on COST. This will
  • decrease 1
  • remain unchanged 2
  • increase 3
  • not enough information 4

24
Matrix linking effectiveness and cost
EFFECTIVENESS decreasing
? recommend experimental treatment X
recommend control ?X neutral ? not enough
evidence judgement required
COST increasing
?

25
Some examples
  • Based on a systematic review
  • chemical patches to reduce premature contractions
    in pregnancy (improves health, saves costs)
  • Based on a randomised trial
  • combined antiretroviral therapy for HIV/no
    therapy (10-23,000 per QALY)

26
The uses of economic evaluation for decisions..
  • Message?
  • Cost-effectiveness doesnt mean it will
    (necessarily) cost less, and more money may still
    need to be found - someone may need to make a
    sacrifice...

27
What is economic evaluation?
  • Comparative analysis of alternative courses of
    action in terms of both their costs and
    consequences.
  • Concerned with EFFICIENCY not just effectiveness
  • doing the same things using less resource
    (technical efficiency)
  • taking resources from an alternative effective
    use because a new use is more effective per
    spent (allocative efficiency - some people lose,
    the social economy gains)

28
Costs and benefits three important steps
  • Always
  • ..identify
  • ..measure
  • ..value
  • Have we included everything that is relevant?
  • Have we counted it?
  • Have we converted it to a common currency?

29
Conclusions
  • The production of health uses resources
  • Both resource use and benefits are important
  • The ideal economic evaluation uses the best
    available evidence on the costs and benefits of
    interventions but what is best evidence?

30
Approaches to combining economic evaluation and
systematic review
31
Approaches to combining economic evaluation and
systematic review
  • Systematic review of economic evaluations
  • Economic evaluation as part of the process of
    systematic review of effectiveness
  • Building an economic model from an existing
    review of effectiveness

32
An exercise on the feasibility of carrying out
secondary economic analyses
  • Economists have not yet developed a formal
    methodology for reviewing and summing up evidence
    from individual economic evaluations ... or
    indeed for assessing whether systematic reviews
    are possible in this context
  • Jefferson T, Mugford M, Gray A, Demicheli V.
    Health Economics 19965155-165

33
  • Reviewers should always be cautious about
    reaching conclusions about implications for
    practice and they should avoid making
    recommendations.
  • Alderson P, Green S, Higgins JPT, editors.
    Cochrane Reviewers Handbook 4.2.1 updated
    December 2003. In The Cochrane Library, Issue
    1, 2004. Chichester, UK John Wiley Sons, Ltd.

34
  • CEAs tend to be riddled with bias and its not
    hard to see that money is the reason for this
  • Given that there is no sensible alternative to
    CEA we need to improve the design, conduct,
    analysis and reporting of such analyses..
  • The key to good reporting comes from recognising
    that CEAs are, in essence, reviews.
  • Rennie 2001
  • J Health Politics Policy and Law

35
The quality of systematic reviews of economic
evaluations in healthcare and what they are
telling us it is time for action
  • Vittorio Demicheli (1,2 )
  • Tom Jefferson (1,2)
  • Luke Vale (2)
  • 1. Health Reviews Ltd, UK
  • 2. Campbell and Cochrane Economics Methods Group
  • JAMA 2001

36
Evidence-based health economicsfrom
effectiveness to efficiency in health care
  • Editors
  • Cam Donaldson University of Calgary
  • Miranda Mugford University of East Anglia
  • Luke Vale, University of Aberdeen
  • Contributors
  • economists and reviewers involved in application
    of economic evaluation in providing and using
    evidence for health care decisions
  • published by BMJ books, spring 2002

37
Joan Robinson said in 1955
  • The purpose of studying economics is not to
    acquire a set of ready-made answers to economic
    questions, but..
  • .to learn how to avoid being deceived by
    economists.

38
See handout
39
Incorporating economics into reviews - groups
  • Choose topic for group
  • Follow flow chart and discuss how each element
    might be approached
  • Agree (three) key areas where further expert
    view/methods guidance is required
Write a Comment
User Comments (0)
About PowerShow.com